首页 > 最新文献

Quality and Safety in Health Care最新文献

英文 中文
254 Improving care for congestive heart failure by transfering competency to specialised nurses 254通过将能力转移给专科护士来改善充血性心力衰竭的护理
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041624.90
J. Patrick, Funck François, Henegariu Viviana, Boireau Amélie, Dagorn Joël, Adalla Dora, B. Michel
Background Chronic Heart failure management is based on ESC recommendations. In most countries, medical therapy is based on a medical examination and despite the improvement of medical therapies; most of CHF patients are not optimally managed. Nurses are more and more implicated in CHF management. Methods We have compared double blind medical prescription of a Heart failure trained Nurse (specific training on CHF, ESC recommendations, BNP use and pathophysiology, patient education) and a heart failure specialised cardiologist in 120 consecutive patients. We focusing on clinical examination, BNP interpretation, treatment evaluation and therapeutic modifications proposed. Results We have included 120 consecutive patients. Mean age was 70.2±5. Mean LVEF was 32±5%. Mean BNP was 230±120 pg/ml NYHA classification was similar in 85% of cases. Treatment evaluation was similar in 89% of the patients and 96% of patients considered as under optimal therapy by the heart failure specialist were identified by the HF nurse. Therapeutic modifications proposed by HF nurse were confirmed by the HF specialist in 85% of the patients. ESC recommendations were followed in 100% of the cases. Differences in prescription between HF nurse and HF specialist are mainly related to spironolactone/Angiotensin II receptor antagonist introduction in addition to ACEI therapy. Conclusion A trained HF nurse could act as first line prescriber in CHF with a low risk profile. Données actuelles La gestion de l'insuffisance cardiaque chronique est basée sur les recommandations de l'ESC. Dans la plupart des pays, le traitement médical repose sur un examen médical et en dépit de l'amélioration des thérapies, la plupart des patients atteints d'ICC ne sont pas géré de façon optimale. Les infirmières sont de plus en plus impliquées dans la gestion de CHF mais ont encore un rôle limité à la prise de cosntantes et de prélèvements. Méthodes Nous avons comparé en double aveugle la prescription médicale d'une infirmière formée spécifiquement à insuffisance cardiaque (formation spécifique sur la maldie, les traitemetns, les bilans et la façon de les interpréter, les recommandations de la société européenne de cardiologie, l'utilisation du BNP et de la physiopathologie, l'éducation des patients) et un cardiologue spécialisé chez 120 patients insuffisants cardiaques consécutifsen nous concentrant sur l'examen clinique, l'interprétation de la BNP, l'évaluation des traitements thérapeutiques et des modifications proposées. Résultats Nous avons inclus 120 patients consécutifs. L'Âge moyen était de 70.2±5. La FEVG moyenne était de 32±5%. Le BNP moyen était de 230±120 pg/ml, la classe NYHA a été similaire dans 85% des cas. Traitement de l'évaluation a été similaire dans 89% des patients et 96% des patients sous traitement considéré comme optimal par le spécialiste en insuffisance cardiaque ont été identifiés comme tels par l'infirmière spécialisée
背景:慢性心力衰竭的管理是基于ESC的建议。在大多数国家,尽管医疗方法有所改进,但医疗仍以医疗检查为基础;大多数慢性心力衰竭患者没有得到最佳治疗。护士越来越多地参与到CHF的管理中。方法:我们比较了一名心衰培训护士(CHF、ESC建议、BNP使用和病理生理学、患者教育方面的专门培训)和一名心衰专科心脏病专家在120例连续患者中的双盲用药处方。我们着重于临床检查、脑钠肽解释、治疗评价和治疗修改建议。结果我们纳入了120例连续患者。平均年龄70.2±5岁。平均LVEF为32±5%。平均BNP为230±120 pg/ml, 85%的病例NYHA分类相似。89%的患者的治疗评价相似,96%的心衰专科医生认为处于最佳治疗状态的患者由心衰护士确定。心衰护理人员提出的治疗方案经心衰专科医生确认为85%的患者。所有病例都遵循了ESC的建议。心衰专科护士与心衰专科医生处方差异主要与ACEI治疗外引入螺旋内酯/血管紧张素II受体拮抗剂有关。结论经过培训的心衰护士可作为心衰患者的一线处方医师,其危险性较低。关于慢性心脏不全症的研究表明,慢性心脏不全症与慢性心脏不全症是一致的。Dans la plupart des pays, le tratrament ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment ment。不确定因素包括不确定因素、不确定因素、不确定因素和不确定因素、不确定因素和不确定因素。方法我们已经比较en双aveugle la处方医学一infirmiere formee specifiquement一insuffisance cardiaque(形成specifique苏尔la maldie les traitemetns les bilans等这样拉·德·莱斯解释器,les recommandations de la法国产品de cardiologie l 'utilisation du BNP et de la physiopathologie,在120例患者中,有1例患者的心血管病病病病,1例患者的心血管病病,1例患者的心血管病病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,1例患者的心血管病,3例患者的心血管病,3例患者的心血管病。该研究包括120名患者。L'Âge moyen samtait de 70.2±5。La FEVG moyenne的比例为32±5%。Le BNP moyen的含量为230±120 pg/ml, la类NYHA的含量为85%。与其他患者相比,有89%的患者和96%的患者认为,与其他患者相比,其他患者认为,与其他患者相比,其他患者认为,与其他患者相比,其他患者认为:与其他患者相比,其他患者认为:与其他患者相比,其他患者认为:与其他患者相比,其他患者认为:与其他患者相比,其他患者认为:修订后的 医疗器械和其他医疗器械的医疗器械和其他医疗器械的医疗器械和其他医疗器械的医疗器械的医疗器械和其他医疗器械的医疗器械的医疗器械的医疗器械的医疗器械。[3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [3] [1] [3] [1] [3] [1] [3] [1] [3] [1] [3]结论:1个病状不全的患者,在心脏不全的情况下,不能进行心脏不全的改良,不能进行心脏不全的改良。
{"title":"254 Improving care for congestive heart failure by transfering competency to specialised nurses","authors":"J. Patrick, Funck François, Henegariu Viviana, Boireau Amélie, Dagorn Joël, Adalla Dora, B. Michel","doi":"10.1136/QSHC.2010.041624.90","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041624.90","url":null,"abstract":"Background Chronic Heart failure management is based on ESC recommendations. In most countries, medical therapy is based on a medical examination and despite the improvement of medical therapies; most of CHF patients are not optimally managed. Nurses are more and more implicated in CHF management. Methods We have compared double blind medical prescription of a Heart failure trained Nurse (specific training on CHF, ESC recommendations, BNP use and pathophysiology, patient education) and a heart failure specialised cardiologist in 120 consecutive patients. We focusing on clinical examination, BNP interpretation, treatment evaluation and therapeutic modifications proposed. Results We have included 120 consecutive patients. Mean age was 70.2±5. Mean LVEF was 32±5%. Mean BNP was 230±120 pg/ml NYHA classification was similar in 85% of cases. Treatment evaluation was similar in 89% of the patients and 96% of patients considered as under optimal therapy by the heart failure specialist were identified by the HF nurse. Therapeutic modifications proposed by HF nurse were confirmed by the HF specialist in 85% of the patients. ESC recommendations were followed in 100% of the cases. Differences in prescription between HF nurse and HF specialist are mainly related to spironolactone/Angiotensin II receptor antagonist introduction in addition to ACEI therapy. Conclusion A trained HF nurse could act as first line prescriber in CHF with a low risk profile. Données actuelles La gestion de l'insuffisance cardiaque chronique est basée sur les recommandations de l'ESC. Dans la plupart des pays, le traitement médical repose sur un examen médical et en dépit de l'amélioration des thérapies, la plupart des patients atteints d'ICC ne sont pas géré de façon optimale. Les infirmières sont de plus en plus impliquées dans la gestion de CHF mais ont encore un rôle limité à la prise de cosntantes et de prélèvements. Méthodes Nous avons comparé en double aveugle la prescription médicale d'une infirmière formée spécifiquement à insuffisance cardiaque (formation spécifique sur la maldie, les traitemetns, les bilans et la façon de les interpréter, les recommandations de la société européenne de cardiologie, l'utilisation du BNP et de la physiopathologie, l'éducation des patients) et un cardiologue spécialisé chez 120 patients insuffisants cardiaques consécutifsen nous concentrant sur l'examen clinique, l'interprétation de la BNP, l'évaluation des traitements thérapeutiques et des modifications proposées. Résultats Nous avons inclus 120 patients consécutifs. L'Âge moyen était de 70.2±5. La FEVG moyenne était de 32±5%. Le BNP moyen était de 230±120 pg/ml, la classe NYHA a été similaire dans 85% des cas. Traitement de l'évaluation a été similaire dans 89% des patients et 96% des patients sous traitement considéré comme optimal par le spécialiste en insuffisance cardiaque ont été identifiés comme tels par l'infirmière spécialisée","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"48 1","pages":"A136 - A137"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83505028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
276 Improving the quality of prostate cancer diagnosis and treatment using shared clinical practice indicators (CPI) and a computerised clinical pathway 276 .利用共享临床实践指标(CPI)和计算机化临床途径提高前列腺癌诊断和治疗的质量
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041616.12
X. Rébillard, B. Ségui, A. Faix, S. A. Hamid, T. Murez, R. Daniel, N. Riolacci, M. Erbault, A. Desplanques, D. Pierre, P. Coloby
Background and Objectives In France, prostate cancer is the most common cancer in men (71 000 new cases expected in 2009) and the second cause of mortality from cancer (8600 deaths expected in 2009). About 180 000 biopsies are made each year, enabling diagnosis of the disease when still at a localised stage in 70% of cases. Radical prostatectomy (RP) (about 25 000 per year) is a therapeutic option for localised cancer requiring the management of the risk of incomplete tumour excision as well as of postoperative functional morbidity. In 2009, the French Parliamentary Office for the Assessment of Health Policies underscored inconsistencies in prostate cancer management that impact on functional morbidity and mortality. Our objective was to develop clinical practice indicators (CPIs) for inclusion in a computerised clinical pathway to be able to propose improvements in care, whether with regard to diagnostic or therapeutic decisions. Programme The CPIs were based on clinical practice guidelines selected by a panel of urologists and validated by the French Association of Urologists (AFU). The innovative computer system Normind-diagnosis was used to calculate CPI values from patient records. The feasibility and quality of CPI data collection by Normind-diagnosis was validated in an analysis of records from five urology departments and national or regional databases (multidisciplinary review of medical records, the pathology database of CRISAP-LR, the national ABLATHERM registry, and the FRANCIM 2001 cohort). The criteria for assessing the quality and safety of diagnostic and therapeutic care in RP patients were: Quality of the histology report (compliance with the recommendations of the AFU Cancer Committee (CCAFU) and the French Society of Pathology), Correct selection of patients eligible for surgery (D' Amico risk classification, comorbidities) and safety of surgery (transfusion rate), Efficacy in oncological terms (negative surgical margins, undetectable PSA at 3 months), and Detection of postoperative functional morbidity and assessment of quality of life (continence at 1 year, erectile dysfunction at 2 years). Results A total of 545 patients with prostate cancer diagnosed in 2007–2008 benefited from CPI monitoring. The CPIs could be calculated from 89% of patient records: In 2008, 100% of biopsy histology reports complied with CCAFU criteria versus 67% in 2007. The D'Amico prognostic group was determined in 98% of patients. For 185 patients who underwent RP, the decision was completely in line with all good practice criteria in 89% of cases; 1% of patients had transfusions. Surgical margins were negative in 84% of patients; 97% had undetectable PSA at 3 months. 91% of patients were totally continent at 1 year. Data for erectile dysfunction are not available. Discussion and Conclusion This computerised clinical pathway using CPIs is currently being implemented by eight urology teams in three regions in France within the framework of a quality res
背景和目的在法国,前列腺癌是男性中最常见的癌症(2009年预计有71 000个新病例),也是癌症死亡的第二大原因(2009年预计有8600人死亡)。每年进行约18万次活组织检查,在70%的病例中,在仍处于局部阶段时就能诊断出疾病。根治性前列腺切除术(RP)(每年约25,000例)是局部癌症的一种治疗选择,需要控制肿瘤切除不完全的风险以及术后功能发病率。2009年,法国议会卫生政策评估办公室强调了影响功能性发病率和死亡率的前列腺癌管理的不一致性。我们的目标是开发临床实践指标(cpi),以纳入计算机化的临床路径,以便能够提出诊断或治疗决策方面的护理改进。CPIs是基于临床实践指南,由泌尿科医师小组选择,并由法国泌尿科医师协会(AFU)验证。使用创新的计算机系统Normind-diagnosis从患者记录中计算CPI值。通过对五个泌尿科和国家或地区数据库(医疗记录的多学科审查、CRISAP-LR病理数据库、国家ABLATHERM登记和FRANCIM 2001队列)的记录分析,验证了Normind-diagnosis收集CPI数据的可行性和质量。评估RP患者诊断和治疗护理质量和安全性的标准是:组织学报告的质量(符合AFU癌症委员会(CCAFU)和法国病理学会的建议),手术患者的正确选择(D' Amico风险分类,合并症)和手术的安全性(输血率),肿瘤学方面的疗效(手术切界阴性,3个月时未检测到PSA),术后功能并发症的检测和生活质量的评估(1年的尿失禁,1年的尿失禁,1年的尿失禁,3年的尿失禁,3年的尿失禁。勃起功能障碍(2岁)。结果2007-2008年共545例前列腺癌患者受益于CPI监测。cpi可以从89%的患者记录中计算出来:2008年,100%的活检组织学报告符合CCAFU标准,而2007年为67%。在98%的患者中确定了D'Amico预后组。在185例接受RP的患者中,89%的患者的决定完全符合所有良好实践标准;1%的患者接受了输血。84%的患者手术切缘呈阴性;97%的患者3个月时PSA未检出。91%的患者在1年时完全康复。没有关于勃起功能障碍的数据。在质量研究计划(PREQHOS)的框架内,目前法国三个地区的八个泌尿科团队正在实施使用cpi的计算机化临床途径。接受RP治疗的局部癌症患者是前瞻性的。这个实践注册将使团队能够交换经验并观察他们在实践中的趋势。第一批结果预计将于2010年公布。”“背景资料:法国公共前列腺癌调查问卷(2009年1人患前列腺癌,71 000例)和死亡率调查问卷(2009年1人患前列腺癌,8600例)。约18万例活组织检查诊断为有效的恶性肿瘤和浸润性肿瘤诊断,其中70%为恶性肿瘤。前列腺切除术(约2.5万例)是一种治疗癌症的方法,可以治疗局部肿瘤。癌症治疗的效果,疾病治疗的功能,疾病治疗后的疗效,疾病治疗后的疗效,疾病治疗后的疗效,疾病治疗后的适应症,疾病治疗后的疗效,疾病治疗后的疗效,疾病治疗后的适应症,疾病治疗后的疗效。2009年,圣<s:1> <s:1>政治评估议会办公室负责对<s:1>健康与死亡评估委员会职能进行评估。目标-方案:临床化学信息学,包括临床化学指标(IPC)、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标、临床化学指标。我将允许“客观条件下的质量保证”和“客观条件下的质量保证”,并允许“客观条件下的质量保证”和“客观条件下的质量保证”。国际预防犯罪委员会(IPC)发布了关于健康行为的建议,以及关于泌尿科医生小组和有效的泌尿科医生和社会组织的建议。Le systemmes information - atique innovative Normind-diagnosis calle IPC - party - data information structure(信息结构)、(档案)、(医疗)、(患者)。 简编》的可行性和质量Normind-diagnosis cpi由计算机系统已经得到验证,通过分析病历5泌尿和数据库服务的国家或区域协商会议(多学科(RCP) CRISAP-LR的病理基础,国家登记册Ablatherm和队列FRANCIM 2001)。该方法允许根据以下标准客观评估局部癌症诊断和治疗的质量和安全性:组织学研究的质量记录(记录是否符合建议CCAFU)、病理学和法国社会公正选拔合格的病人做手术(' amico, co-morbidités group)和安全输血的手术治疗(率)、carcinologique (d’exérèse负面边际效率和PSA检测不到3个),确定术后功能后遗症和患者的生活质量(1年失禁率,2年勃起功能障碍)。结果对2007 - 2008年确诊的545例前列腺癌患者进行了临床实践指标监测。医疗记录数据允许计算89%患者的cpi,结果如下:2008年,100%的前列腺活检组织学报告符合CCAFU的质量标准,而2007年为67%。98%的患者确定了amico的预后组。在185例前列腺切除术患者中,89%的患者的决定是完整的,并符合良好实践指南的所有标准。1%的人输血。84%的患者的行距为阴性,97%的患者在3个月时PSA检测不到。91%的患者在1岁时完全消失。目前还没有勃起功能障碍的数据。在一项质量研究计划(PREQHOS)的框架内,目前正在法国3个地区的8个泌尿科医生团队中建立基于IPC的计算机临床路径,其中包括前列腺切除术治疗局部癌症的患者。这个练习日志将允许团队交流他们的练习,并对每个练习进行跟踪,以跟踪他们的练习的发展。第一个结果预计将于2010年公布。
{"title":"276 Improving the quality of prostate cancer diagnosis and treatment using shared clinical practice indicators (CPI) and a computerised clinical pathway","authors":"X. Rébillard, B. Ségui, A. Faix, S. A. Hamid, T. Murez, R. Daniel, N. Riolacci, M. Erbault, A. Desplanques, D. Pierre, P. Coloby","doi":"10.1136/QSHC.2010.041616.12","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041616.12","url":null,"abstract":"Background and Objectives In France, prostate cancer is the most common cancer in men (71 000 new cases expected in 2009) and the second cause of mortality from cancer (8600 deaths expected in 2009). About 180 000 biopsies are made each year, enabling diagnosis of the disease when still at a localised stage in 70% of cases. Radical prostatectomy (RP) (about 25 000 per year) is a therapeutic option for localised cancer requiring the management of the risk of incomplete tumour excision as well as of postoperative functional morbidity. In 2009, the French Parliamentary Office for the Assessment of Health Policies underscored inconsistencies in prostate cancer management that impact on functional morbidity and mortality. Our objective was to develop clinical practice indicators (CPIs) for inclusion in a computerised clinical pathway to be able to propose improvements in care, whether with regard to diagnostic or therapeutic decisions. Programme The CPIs were based on clinical practice guidelines selected by a panel of urologists and validated by the French Association of Urologists (AFU). The innovative computer system Normind-diagnosis was used to calculate CPI values from patient records. The feasibility and quality of CPI data collection by Normind-diagnosis was validated in an analysis of records from five urology departments and national or regional databases (multidisciplinary review of medical records, the pathology database of CRISAP-LR, the national ABLATHERM registry, and the FRANCIM 2001 cohort). The criteria for assessing the quality and safety of diagnostic and therapeutic care in RP patients were: Quality of the histology report (compliance with the recommendations of the AFU Cancer Committee (CCAFU) and the French Society of Pathology), Correct selection of patients eligible for surgery (D' Amico risk classification, comorbidities) and safety of surgery (transfusion rate), Efficacy in oncological terms (negative surgical margins, undetectable PSA at 3 months), and Detection of postoperative functional morbidity and assessment of quality of life (continence at 1 year, erectile dysfunction at 2 years). Results A total of 545 patients with prostate cancer diagnosed in 2007–2008 benefited from CPI monitoring. The CPIs could be calculated from 89% of patient records: In 2008, 100% of biopsy histology reports complied with CCAFU criteria versus 67% in 2007. The D'Amico prognostic group was determined in 98% of patients. For 185 patients who underwent RP, the decision was completely in line with all good practice criteria in 89% of cases; 1% of patients had transfusions. Surgical margins were negative in 84% of patients; 97% had undetectable PSA at 3 months. 91% of patients were totally continent at 1 year. Data for erectile dysfunction are not available. Discussion and Conclusion This computerised clinical pathway using CPIs is currently being implemented by eight urology teams in three regions in France within the framework of a quality res","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"1 1","pages":"A35 - A36"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90334289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
112 Why perform bacterial identifications and antibiotic sensitivity analyses during night shifts in a bacteriology laboratory in a university medical centre? 112为什么要在大学医学中心细菌学实验室的夜班期间进行细菌鉴定和抗生素敏感性分析?
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041624.6
E. Matthieu, L. Carole, C. Jané, Hitoto Hikombo, Mahaza Chetaou, Kempf Marie, Joly-Guillou Marie-Laure
Background, objective After opening hours, the activity of a clinical microbiology laboratory (CML) is usually limited to the inoculation of specimens sent by clinical wards and gram-stain examinations. A continuous functioning (CF) has been implemented for the last 4 years in the CML of Angers teaching hospital. With the CF, in addition to gram-stain examination and inoculations, urine cultures, blood cultures and cultures from certain fluids (ascitis, articular, pleural, perioperative, cerebrospinal) are monitored two or three times every night. In the case of colony growth, bacterial identifications (BI) and susceptibility to antibiotics testing (SAT) are performed. Concurrently to a geographical grouping of our hospital laboratories expected in 2010, the permanence of the CT is questioned. Therefore, our objective was to assess its interest in order to maintain it. Program: description, implementation, follow-up For each specimen for whom a BI and/or SAT were performed by night, the impact of the CF was assessed in terms of decrease in the delays from the time of sampling to the time at which results became available, and in terms of consequences of this decrease for the management of patient antimicrobial treatments. The delays in the absence of CF were estimated by considering the laboratory opening hours in the absence of CF and delays in incubation necessary for BI and SAT. Two major benefits have been defined: the early implementation of an effective treatment (EIET) and the early change to a reduced-spectrum but still efficient regimen (ECRR). The decrease of the delay was either 24 h or 48 h. Results in terms of clinical impact During the 4 months of the study, a BI and/or a SAT were performed for 430 specimens during the night period. An EIET was reported for 97 samples (22.6%), representing a cumulative gain of 111 days. For 49 patients, this EIET corresponded to the modification of an ineffective treatment, and for the 48 others, it corresponded to the implementation of an effective treatment in a patient not treated. An EIET was observed in 37.9% of blood cultures, 20.8% of urine cultures, and 17.9% of fluid cultures concerned by the night activity. An ECRR was reported for 23 samples accounting for 5.4% of overall specimens and representing 29 days of treatment. Among the nine wards for which the CF was the most profitable in terms of EIET, there were seven medical and two surgical wards. Therefore, there was no intensive care unit (ICU) among those wards. Similarly, the medical ICU was only in fourth position in terms of ECRR. Discussion, conclusion Even though an economical study would have been useful, this system, unique in France, is helpful to improve the proper use of antibiotics. Unlike a classic night functioning for whom the results of gram-stain examinations are reported by night, often in the absence of clinician, the night activity in our CF allows to provide results during the day period (with 24 or 48 h in advance),
方案:执行、监测内容为描述每个采样为其中一个IB和/或AB夜色已取得的利润来接管了病人的治疗进行比较,评价结果的退款期限与FC获得退款期限估计没有FC(考虑到文化的时间记录和实验室的时刻表,一方面FC)以外,另一方面,将服务部门作出的治疗决定与结果联系起来。已经确定了两种主要的好处:在实施有效治疗(GTTE)方面节省了时间,在节省通常定义为储备和/或广谱抗生素(GTAR)方面节省了时间。节省的时间是24小时或48小时。在4个月的研究中,对430个样本进行了夜间bi和/或AB测试。97个样本(22.6%)观察到GTTE,总增益为111天。49例患者的GTTE对应于无效治疗的改变,其余48例患者的GTTE对应于未治疗患者的有效治疗。37.9%的血液培养、20.8%的ebu和17.9%的cf穿刺均观察到GTTE。23个样本(5.4%)观察到GTAR,代表29天的处理。就GTTE而言,cf最具成本效益的9个服务包括7个医疗服务(包括急诊)和2个外科服务,但矛盾的是没有复苏服务。同样,医疗复苏在GTAR中排名第四。尽管一项经济研究可能是有用的,但这个在法国独一无二的系统是帮助正确使用抗生素的工具。像一个经典的监护制度,对于考试结果常常夜里自首后,直接缺席我们的临床医生,夜间活动的业绩FC使系统提前一天与24ou(48小时),因此临床医生在场antibiothérapies大四学生更适合建立或修改。为了提高cf的成本效益,我们计划排除一些贡献不大的分析(如探针尿液),代之以其他分析(如深部肺取样),在这些分析中,早期报告结果可能会影响抗生素处方。
{"title":"112 Why perform bacterial identifications and antibiotic sensitivity analyses during night shifts in a bacteriology laboratory in a university medical centre?","authors":"E. Matthieu, L. Carole, C. Jané, Hitoto Hikombo, Mahaza Chetaou, Kempf Marie, Joly-Guillou Marie-Laure","doi":"10.1136/QSHC.2010.041624.6","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041624.6","url":null,"abstract":"Background, objective After opening hours, the activity of a clinical microbiology laboratory (CML) is usually limited to the inoculation of specimens sent by clinical wards and gram-stain examinations. A continuous functioning (CF) has been implemented for the last 4 years in the CML of Angers teaching hospital. With the CF, in addition to gram-stain examination and inoculations, urine cultures, blood cultures and cultures from certain fluids (ascitis, articular, pleural, perioperative, cerebrospinal) are monitored two or three times every night. In the case of colony growth, bacterial identifications (BI) and susceptibility to antibiotics testing (SAT) are performed. Concurrently to a geographical grouping of our hospital laboratories expected in 2010, the permanence of the CT is questioned. Therefore, our objective was to assess its interest in order to maintain it. Program: description, implementation, follow-up For each specimen for whom a BI and/or SAT were performed by night, the impact of the CF was assessed in terms of decrease in the delays from the time of sampling to the time at which results became available, and in terms of consequences of this decrease for the management of patient antimicrobial treatments. The delays in the absence of CF were estimated by considering the laboratory opening hours in the absence of CF and delays in incubation necessary for BI and SAT. Two major benefits have been defined: the early implementation of an effective treatment (EIET) and the early change to a reduced-spectrum but still efficient regimen (ECRR). The decrease of the delay was either 24 h or 48 h. Results in terms of clinical impact During the 4 months of the study, a BI and/or a SAT were performed for 430 specimens during the night period. An EIET was reported for 97 samples (22.6%), representing a cumulative gain of 111 days. For 49 patients, this EIET corresponded to the modification of an ineffective treatment, and for the 48 others, it corresponded to the implementation of an effective treatment in a patient not treated. An EIET was observed in 37.9% of blood cultures, 20.8% of urine cultures, and 17.9% of fluid cultures concerned by the night activity. An ECRR was reported for 23 samples accounting for 5.4% of overall specimens and representing 29 days of treatment. Among the nine wards for which the CF was the most profitable in terms of EIET, there were seven medical and two surgical wards. Therefore, there was no intensive care unit (ICU) among those wards. Similarly, the medical ICU was only in fourth position in terms of ECRR. Discussion, conclusion Even though an economical study would have been useful, this system, unique in France, is helpful to improve the proper use of antibiotics. Unlike a classic night functioning for whom the results of gram-stain examinations are reported by night, often in the absence of clinician, the night activity in our CF allows to provide results during the day period (with 24 or 48 h in advance),","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"2 1","pages":"A52 - A53"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75222436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
149 Follow-up of adverse events in a neonatal intensive care unit 149例新生儿重症监护病房不良事件的随访
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041624.46
L. Stephanie, Razafimahefa Hasinirina, Sgaggero Betty, Brosseau Martine
Context Iatrogenic incidents, major public health problem, can be responsible for damage and serious after-effects, particularly in neonates. They would be responsible for complications in 10% of the hospital admittances. Newborn children are particularly exposed to these iatrogenic risks. Several studies showed that these incidents increase significantly the risk of morbi-mortality in paediatric departments. Only few data are available on their incidence and consequences in neonatology. Objective of this work was to determine the epidemiology of iatrogenic risks in neonates, to look for answers to these dysfunctions and to sensitise medical and paramedical professionals to this public health problem. Description of the program A multidisciplinary group called ‘Amélioration des soins à l'enfant’, with monthly medical and paramedical meetings for synthesis and exposition of the results, was created in 2005. The group defined the methodology of the program, set up a continuous statement of adverse events (AE), analysed the data and identified corrective actions to AE. In 2008, this approach was continued with modified objectives and two nurses were associated in the five following domains: respiratory, intravenous, oral tract and skin incidents and incidents concerning the management and the organisation of care. An anonymised form was created in each domain to improve the exhaustiveness of the data. Results In 2005, 171/248 (70%) of the AE concerned the parenteral route, especially central (45%). Twenty cases of catheter removal secondarily to catheter obstruction were collected. Identification of the causes of these obstructions allowed the introduction of corrective actions (reprogramming of pumps, change in use of solutions). Thus, obstructions became less frequent (6) and did not require catheter removal any more. From November 2008 to January 2009, 205 AE were collected. The main problem identified was the presence of water in the respiratory tubes during non-invasive ventilation (30/93 cases of respiratory incidents), responsible for episodes of deep bradycardia and desaturations in children. Contacts with biomedical service, with other neonatal intensive care units and with tube manufacturers demonstrated that the solution was to use another equipment (dual hose heater adaptator for respiratory system) to avoid condensation. An inventory of our equipment followed by the purchase of all the necessary material at the beginning of February 2009 allowed the disappearance of this AE within our department. Discussion Improvement of the tool to collect AE is the principal objective of our group. It will allow a better exhaustiveness and then, a more rapid reaction in the introduction of corrective actions. Other objectives are the information and the knowledge updating of health care workers and the review or the elaboration of new protocols. One limit of this work is the reluctance of health care workers to report AE, as they consider AE as a r
医源性事件是一个重大的公共卫生问题,可能造成损害和严重的后遗症,特别是对新生儿。他们要为10%的住院病人的并发症负责。新生儿特别容易受到这些医源性风险的影响。几项研究表明,这些事件显著增加了儿科发病死亡率的风险。关于其在新生儿中的发病率和后果的数据很少。这项工作的目的是确定新生儿医源性风险的流行病学,寻找这些功能障碍的答案,并使医疗和辅助医疗专业人员对这一公共卫生问题更加敏感。2005年设立了一个多学科小组,名为"儿童健康和健康状况综合评估",每月召开一次医疗和辅助医疗会议,以综合和阐述研究成果。小组定义了项目的方法,建立了不良事件(AE)的连续声明,分析了数据并确定了针对AE的纠正措施。2008年,这一方法在修改目标后继续进行,两名护士负责以下五个领域:呼吸、静脉、口腔和皮肤事件以及与护理管理和组织有关的事件。在每个域中创建了一个匿名表单,以提高数据的详尽性。结果2005年有171/248例(70%)的AE与肠外途径有关,以中心部位为主(45%)。我们收集了20例继发导管梗阻拔管的病例。确定这些障碍的原因,可以采取纠正措施(泵的重新编程,改变溶液的使用)。因此,阻塞次数减少(6),不再需要拔除导管。2008年11月至2009年1月共收集AE 205例。确定的主要问题是在无创通气期间呼吸管中存在水(93例呼吸事件中有30例),这是儿童深度心动过缓和去饱和发作的原因。与生物医学服务部门、其他新生儿重症监护病房和管道制造商的接触表明,解决方案是使用另一种设备(呼吸系统双软管加热器适配器)以避免冷凝。2009年2月初,我们对设备进行了盘点,随后购买了所有必要的材料,这使得我们部门内的AE消失了。改进收集声发射的工具是我们小组的主要目标。它将允许更好地穷尽,然后在采取纠正行动方面作出更迅速的反应。其他目标是更新卫生保健工作者的信息和知识,审查或拟订新的议定书。这项工作的一个限制是卫生保健工作者不愿意报告AE,因为他们认为AE是对他们专业技能的重新考虑。必须继续开展信息、团队培训和再保险工作,以尽量减少这些不情愿。重视工作组和医疗小组的交流(在服务委员会定期介绍工作组的工作,在2006年的"关于<s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1>新闻组织"会议上进行交流,在2006年11月向专家进行交流,在2009年3月的" <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1>新闻组织"会议上进行交流)也得到了领导。结论:该小组的工作使专业实践有了显著的改善,对医疗保健专业人员和患者都产生了重大影响。它允许估计声发射的发生率,并提出解决问题的方法的例子。事故事故、重大公共问题、预防责任人、特别是组织机构、组织机构、组织机构、组织机构、组织机构、组织机构、组织机构和组织机构。并发症的次要来源占入院率的10%。“新变”是一种特殊的行为,它暴露了“变变”所带来的风险。在监测事件中使用了大量的电子烟,增加了事件的重要性,减少了患病和死亡的风险,减少了服务中的电子烟。不确定的薪金是由不确定的薪金引起的,薪金是由不确定的薪金引起的。目标是研究如何解决失调的问题,研究人员如何解决失调的问题,研究人员如何解决失调的问题,研究人员如何解决失调的问题,研究人员如何解决失调的问题,研究人员如何解决失调的问题。方案说明联合国小组"多学科、综合、恢复和调整、综合、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整、调整和调整。
{"title":"149 Follow-up of adverse events in a neonatal intensive care unit","authors":"L. Stephanie, Razafimahefa Hasinirina, Sgaggero Betty, Brosseau Martine","doi":"10.1136/QSHC.2010.041624.46","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041624.46","url":null,"abstract":"Context Iatrogenic incidents, major public health problem, can be responsible for damage and serious after-effects, particularly in neonates. They would be responsible for complications in 10% of the hospital admittances. Newborn children are particularly exposed to these iatrogenic risks. Several studies showed that these incidents increase significantly the risk of morbi-mortality in paediatric departments. Only few data are available on their incidence and consequences in neonatology. Objective of this work was to determine the epidemiology of iatrogenic risks in neonates, to look for answers to these dysfunctions and to sensitise medical and paramedical professionals to this public health problem. Description of the program A multidisciplinary group called ‘Amélioration des soins à l'enfant’, with monthly medical and paramedical meetings for synthesis and exposition of the results, was created in 2005. The group defined the methodology of the program, set up a continuous statement of adverse events (AE), analysed the data and identified corrective actions to AE. In 2008, this approach was continued with modified objectives and two nurses were associated in the five following domains: respiratory, intravenous, oral tract and skin incidents and incidents concerning the management and the organisation of care. An anonymised form was created in each domain to improve the exhaustiveness of the data. Results In 2005, 171/248 (70%) of the AE concerned the parenteral route, especially central (45%). Twenty cases of catheter removal secondarily to catheter obstruction were collected. Identification of the causes of these obstructions allowed the introduction of corrective actions (reprogramming of pumps, change in use of solutions). Thus, obstructions became less frequent (6) and did not require catheter removal any more. From November 2008 to January 2009, 205 AE were collected. The main problem identified was the presence of water in the respiratory tubes during non-invasive ventilation (30/93 cases of respiratory incidents), responsible for episodes of deep bradycardia and desaturations in children. Contacts with biomedical service, with other neonatal intensive care units and with tube manufacturers demonstrated that the solution was to use another equipment (dual hose heater adaptator for respiratory system) to avoid condensation. An inventory of our equipment followed by the purchase of all the necessary material at the beginning of February 2009 allowed the disappearance of this AE within our department. Discussion Improvement of the tool to collect AE is the principal objective of our group. It will allow a better exhaustiveness and then, a more rapid reaction in the introduction of corrective actions. Other objectives are the information and the knowledge updating of health care workers and the review or the elaboration of new protocols. One limit of this work is the reluctance of health care workers to report AE, as they consider AE as a r","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"28 1","pages":"A92 - A93"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77097056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
159 Sleep apnoea: clinical impact of a quality improvement program using an Internet-based registry 睡眠呼吸暂停:使用基于互联网注册的质量改进项目的临床影响
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041608.9
J. Pépin, G. Huchon, Y. Grillet, M. Sapéne, A. Vicente, B. Housset, Au Nom Des Membres De L'osfp
Background and Objectives The national French Registry to evaluate sleep breathing disorders (OSFP Registry: Observatoire sommeil de la Fédération de Pneumologie) is intended to collect updated information about current practices of respiratory physicians managing sleep apnoea patients. Methods, Program Description and Follow-up The main goal of the Internet-based registry (www.osfp.fr) is to improve clinical management quality by offering respiratory physicians a complete and systematically organised online evaluation of patients referred for sleep disorders. The content of the registry addresses four goals: (1) to improve physician's knowledge not only of sleep apnoea but also of alternative diagnosis by the systematic use of validated clinical scales for sleepiness, fatigue, depression and restless legs syndrome, (2) to increase awareness of comorbidities and cardio-metabolic risk associated with sleep apnoea, by suggesting measurements of waist circumference, blood pressure, fasting lipids and fasting glucose, (3) to identify subgroups of at-risk patients (ie obesity hypoventilation and a combination of chronic obstructive pulmonary disease and sleep apnoea, the so-called overlap syndrome), and (4) to suggest appropriate follow-up and treatments for these specific subgroups of patients according to national guidelines. Information from the database is available at anytime and data can be extracted for statistical analysis. Participating physicians can compare their practices with others’ in the registry and with the guidelines established with the French High Health authority (HAS: Haute Autorité de Santé). Results in terms of clinical impact More than 560 centres were involved and between January 2007 and November 2009, more than 22 000 suspected sleep apnoea patients were enrolled. These centres included varied clinical practices, reflecting real life sleep apnoea clinical management in France. The majority of centres were private practices (74% of the patients) whilst others were public hospital practices, either teaching university hospitals (4% of the patients) or district hospitals (22% of the patients). Patients from all regions of France were included and constitute a representative sample in terms of places of residence, rural/urban ratio and socio-professional groups. Sleep apnoea was diagnosed in 80% of referred patients and CPAP prescribed in 70% of them, with a mean CPAP usage of 5.7 h/night which is higher than the usually reported compliance in clinical studies (Cochrane 2009: 5.5 h/night). Significant improvement occurred with reduction in the sleepiness, fatigue and depression scales (from 12 to 8, 14 to 9 and 6 to 4.5, respectively). Appropriate characterisation of the patients at baseline allowed the identification of cardiovascular comorbidities in 45% of the patients. A significant percentage of patients (11%) were referred to cardiologist or other specialists after associated or alternative diagnosis had been appropr
背景和目的:法国国家睡眠呼吸障碍评估登记处(OSFP登记处:Observatoire sommeil de la f<s:1> <s:1> <s:1> <s:1> <s:1> <s:1>呼吸系统<s:1> <s:1> <s:1>呼吸系统<e:1>)旨在收集当前呼吸内科医生管理睡眠呼吸暂停患者实践的最新信息。方法、项目描述和随访基于互联网的注册(www.osfp.fr)的主要目标是通过为呼吸内科医生提供一个完整的、系统组织的睡眠障碍患者在线评估来提高临床管理质量。注册表的内容涉及四个目标:(1)提高医生对睡眠呼吸暂停的认识,并通过系统地使用经过验证的嗜睡、疲劳、抑郁和不宁腿综合征的临床量表,提高医生对睡眠呼吸暂停相关的合并症和心脏代谢风险的认识,建议测量腰围、血压、空腹血脂和空腹血糖;(3)确定高危患者亚组(即肥胖、低通气和慢性阻塞性肺疾病合并睡眠呼吸暂停,即所谓的重叠综合征),(4)根据国家指南对这些特定亚组患者提出适当的随访和治疗建议。数据库中的信息随时可用,并可提取数据进行统计分析。参与的医生可以将他们的做法与登记处的其他人的做法以及与法国高级卫生当局(HAS: Haute autorit<e:1> de sant<e:1>)制定的指导方针进行比较。在2007年1月至2009年11月期间,超过560个中心参与了这项研究,超过22000名疑似睡眠呼吸暂停患者被纳入研究。这些中心包括各种临床实践,反映了法国现实生活中的睡眠呼吸暂停临床管理。大多数中心是私人诊所(占患者的74%),而其他中心是公立医院诊所,要么是大学教学医院(占患者的4%),要么是地区医院(占患者的22%)。来自法国所有地区的患者被纳入研究,在居住地、城乡比例和社会专业群体方面构成了具有代表性的样本。80%的患者被诊断为睡眠呼吸暂停,其中70%的患者使用CPAP,平均CPAP使用5.7小时/晚,高于临床研究中通常报道的依从性(Cochrane 2009: 5.5小时/晚)。嗜睡、疲劳和抑郁量表(分别从12降至8、14降至9和6降至4.5)均有显著改善。在基线时对患者进行适当的特征描述,可以在45%的患者中发现心血管合并症。相当比例的患者(11%)在相关或替代诊断得到适当认可后转介给心脏病专家或其他专家。迄今为止,50%的肥胖患者接受了血气和肺功能测试。11.8%的肥胖患者被诊断为肥胖低通气综合征,导致在最严重的病例中使用CPAP或无创通气处方。基线评估期间肺功能检查异常导致2.8%的被调查患者使用支气管扩张剂。讨论与结论:该质量控制项目使用基于互联网的注册表,可以描述睡眠障碍患者的关键人口学特征,并对法国呼吸内科医生目前对睡眠呼吸暂停患者的做法和治疗管理进行评估。该系统旨在促使呼吸内科医生在评估和跟踪睡眠障碍患者时使用广泛的诊断工具。护理人员可以比较他们自己的做法和现行的指导方针。对于患者来说,呼吸道和非呼吸道合并症都得到了更系统的识别和适当的处理。最后,注册是评估全国指南有用性和改善患者护理的适当工具。背景与目的:收集<s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1>与<s:1> <s:1>················收集<s:1> <s:1> <s:1>与<s:1>······························项目说明,通过互联网注册(www.osfp.fr),通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册,通过网络注册。 该中心有四个提高质量的目标:(i)增加从业人员对睡眠呼吸暂停综合征以及鉴别或相关诊断的知识。为此,他们被建议系统地使用经过验证的嗜睡、疲劳、抑郁和不宁腿综合征严重程度的临床量表。(ii)扩大检查范围,寻找疾病的共病,并通过测量血压、脐带周长和生物检查记录心血管风险。(三)鼓励下鉴定高风险患者群体的肥胖的并发症和死亡率(hypoventilateurs d’apnées综合征之间或联系一个copd和昏睡病)、(四)提出并组织一个后续并给予适当的治疗,这些患者亚组不同国家同意的建议。根据不断提供的统计分析,参与中心的从业人员可以随时将他们的做法与其他中心的做法以及与高级卫生当局正在制定的临床做法建议进行比较。在临床影响方面,超过560个中心参与监测,在2007年1月至2009年11月期间,超过22000名疑似睡眠呼吸暂停患者被列入登记册。参与的中心对应着不同的运动模式,反映了法国睡眠呼吸暂停综合症管理的“真实生活”(分别占74名、22名和4%的患者的自由实践、综合医院和大学医院)。患者来自法国所有地区,在居住地、农村/城市栖息地和社会专业类别分布方面具有代表性。80%的患者被诊断为睡眠呼吸暂停综合征,70%的患者建议持续正压,平均使用5.7小时/晚,高于临床研究报告的依从性(Cochrane 2009: 5.5小时/晚)。临床改善,困倦、疲劳和抑郁得分显著降低(分别为12 - 8,14 - 9,6 - 4,5)。在最初的评估中,对患者进行准确的描述可以在45%的病例中发现心血管共病。11%的患者被转介给心脏病专家或其他专家,因为初步检查确定了相关诊断。11.8%的患者被诊断为通气不足肥胖综合征,这使得在最严重的病例中,患者可以转向无创通气。呼吸功能测试导致2.8%的患者开始支气管扩张剂治疗。讨论-结论这个基于互联网的实践评估项目提高了睡眠呼吸暂停管理的质量,这对患者有直接的好处,同时提供了流行病学数据。这种操作模式鼓励从业者使用诊断和评估工具,而不是他们自己的专业。对患者的影响是更好地识别共病和相关病理,从而允许更有效的管理。
{"title":"159 Sleep apnoea: clinical impact of a quality improvement program using an Internet-based registry","authors":"J. Pépin, G. Huchon, Y. Grillet, M. Sapéne, A. Vicente, B. Housset, Au Nom Des Membres De L'osfp","doi":"10.1136/QSHC.2010.041608.9","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041608.9","url":null,"abstract":"Background and Objectives The national French Registry to evaluate sleep breathing disorders (OSFP Registry: Observatoire sommeil de la Fédération de Pneumologie) is intended to collect updated information about current practices of respiratory physicians managing sleep apnoea patients. Methods, Program Description and Follow-up The main goal of the Internet-based registry (www.osfp.fr) is to improve clinical management quality by offering respiratory physicians a complete and systematically organised online evaluation of patients referred for sleep disorders. The content of the registry addresses four goals: (1) to improve physician's knowledge not only of sleep apnoea but also of alternative diagnosis by the systematic use of validated clinical scales for sleepiness, fatigue, depression and restless legs syndrome, (2) to increase awareness of comorbidities and cardio-metabolic risk associated with sleep apnoea, by suggesting measurements of waist circumference, blood pressure, fasting lipids and fasting glucose, (3) to identify subgroups of at-risk patients (ie obesity hypoventilation and a combination of chronic obstructive pulmonary disease and sleep apnoea, the so-called overlap syndrome), and (4) to suggest appropriate follow-up and treatments for these specific subgroups of patients according to national guidelines. Information from the database is available at anytime and data can be extracted for statistical analysis. Participating physicians can compare their practices with others’ in the registry and with the guidelines established with the French High Health authority (HAS: Haute Autorité de Santé). Results in terms of clinical impact More than 560 centres were involved and between January 2007 and November 2009, more than 22 000 suspected sleep apnoea patients were enrolled. These centres included varied clinical practices, reflecting real life sleep apnoea clinical management in France. The majority of centres were private practices (74% of the patients) whilst others were public hospital practices, either teaching university hospitals (4% of the patients) or district hospitals (22% of the patients). Patients from all regions of France were included and constitute a representative sample in terms of places of residence, rural/urban ratio and socio-professional groups. Sleep apnoea was diagnosed in 80% of referred patients and CPAP prescribed in 70% of them, with a mean CPAP usage of 5.7 h/night which is higher than the usually reported compliance in clinical studies (Cochrane 2009: 5.5 h/night). Significant improvement occurred with reduction in the sleepiness, fatigue and depression scales (from 12 to 8, 14 to 9 and 6 to 4.5, respectively). Appropriate characterisation of the patients at baseline allowed the identification of cardiovascular comorbidities in 45% of the patients. A significant percentage of patients (11%) were referred to cardiologist or other specialists after associated or alternative diagnosis had been appropr","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"27 1","pages":"A11 - A12"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84701478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
282 Reducing the iatrogenicity of neuroleptics in patients with Alzheimer's disease 282降低阿尔茨海默病患者抗精神病药的医原性
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041608.21
A. Desplanques-Leperre, N. Riolacci-Dhoyen, M. Erbault, L. Banaeï-Bouchareb, C. Chan-Chee, J. Deligne, V. Corre, P. Ricordeau, B. Lavallart
Background and Objectives Neuroleptics (NL) are often prescribed to patients with Alzheimer's disease (AD), mainly for behaviour disorders and during episodes of confusion. However, these drugs are known to have frequent and severe iatrogenic effects: treating 1000 patients with behaviour disorders receiving NL for 12 weeks would result in 10 additional deaths, 18 strokes (half of which were severe), additional 58 to 94 cases of gait disorders and only 91 to 200 decrease in behaviour disorders. In fact, all AD patients will present behaviour disorders at some time or other. The French Alzheimer public health plan aims to reduce the avoidable iatrogenic effects of NL. Program The national cooperative group for the optimisation of the prescription of psychotropic drugs in the elderly was established at the initiative of HAS. Its members include nurses, patients, insurers and institutions. A problem-solving approach centred on the patient pathway that included three quality dimensions (Efficacy (E), Safety (S) and Access to best care (A)) was used to develop and implement the tools to achieve an integrated programme going ‘from practice improvement to clinical impact measurement’. The practice improvement part which is aimed at reducing the iatrogenic effects of NL in AD patients includes: (1) identification of AD patients with NL (local warning signal=percentage of AD patients taking NL). This indicator is easy to measure in all care sectors and comes with a good practice indicator ‘absence of daytime sedation’ and monitoring of prescriptions for other psychotropic drugs to prevent drug switching, (2) review of prescriptions for identified AD patients in order to correct inappropriate prescriptions (local indicator for risk containment=percentage of prescriptions reviewed for AD patients), and (3) two new guidelines on behaviour disorders in AD patients and on confusion in the elderly that describe proper use of NL and other psychotropic drugs (E, S) as well as new nondrug techniques of care (A). Reduction of exposure to NL before and after prescription is based on these guidelines. Clinical impact is given by the national rate of exposure of AD patients to NL and is measured in the French AD patient population covered by the three main sickness funds. Results The first national measures in 2007 on 400 000 AD patients showed that exposure to NL in AD patients was five times higher (16.95%) than in the general population of the same age (2.9%). One year after the Alzheimer plan was launched and after raising the awareness of families and health professionals to the risks of NL, exposure had fallen slightly to 16.1% (equivalent to 3500 fewer cases of exposure). The above programme is in the process being implemented. Results for the national warning signal have been widely diffused. The programme is supported by training initiatives and information campaigns aimed at the general public, the families of AD patients, and health professionals. These are
背景和目的神经抑制剂(NL)常用于阿尔茨海默病(AD)患者,主要用于治疗行为障碍和精神错乱发作。然而,已知这些药物具有频繁和严重的医源性影响:接受NL治疗1000名行为障碍患者12周将导致10例额外死亡,18例中风(其中一半是严重的),额外58至94例步态障碍,行为障碍仅减少91至200例。事实上,所有AD患者都会在某个时候出现行为障碍。法国阿尔茨海默病公共卫生计划旨在减少NL可避免的医源性影响。方案在社会保障局的倡议下,成立了全国老年人精神药物处方优化合作小组。其成员包括护士、病人、保险公司和机构。以患者途径为中心的解决问题的方法,包括三个质量维度(疗效(E),安全性(S)和获得最佳护理(A)),用于开发和实施工具,以实现“从实践改进到临床影响测量”的综合计划。旨在降低NL对AD患者医源性影响的实践改进部分包括:(1)识别NL的AD患者(局部警示信号=服用NL的AD患者百分比)。这一指标在所有护理部门都很容易衡量,并附带一个良好做法指标“白天不使用镇静剂”和监测其他精神药物的处方以防止药物转换。(2)审查已确定的AD患者的处方,以纠正不适当的处方(风险控制的地方指标=审查AD患者处方的百分比)。(3)关于阿尔茨海默病患者行为障碍和老年人精神混乱的两项新指南,描述了NL和其他精神药物的正确使用(E, S)以及新的非药物护理技术(A)。在处方前后减少NL的暴露是基于这些指南。临床影响是由国家的广告的接触率测量病人问和在法国AD患者人群覆盖的三种主要疾病基金。结果第一个国家措施在2007年400年000年广告表明AD患者暴露于问患者(16.95%)高出5倍比同龄的普通人群(2.9%)。在阿尔茨海默计划启动一年后,在提高了家庭和卫生专业人员对NL风险的认识之后,接触率略有下降,降至16.1%(相当于减少了3500例接触病例)。上述方案正在执行过程中。国家预警信号的结果已经广泛传播。该方案得到了针对公众、老年痴呆症患者家属和保健专业人员的培训倡议和宣传运动的支持。这些是由阿尔茨海默计划,HAS和专业学院进行的。上述方案将医生、护士、病人、家属和保健机构联合起来。背景-目的:神经衰弱症(NL)与阿尔茨海默症(MA)、行为原则障碍(dans)、障碍(dans)、障碍(dans)、障碍(dans)、障碍(csm)、障碍(csm)、障碍(csm)之间的关系。从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,从医学上看,这是一个很好的例子。或者,我们的研究对象是老年痴呆症患者,我们的研究对象是老年痴呆症患者,我们的研究对象是老年痴呆症患者。方案:全国合作组织- - -改善精神药物处方- - - <s:2> - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -1 .我们分析了"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"、"解决问题的办法"。全国范围内的交换交换方案:交换交换交换的交换交换方案:交换交换交换的交换交换方案。 依据是(i)确定我国地方NL(指标预警下容易测量的MA = % NL之下的)不管护理部门的良好做法,以及执行一项指标上没有任何白昼镇静,后续其他处方药物以防止reports。;(二)评审时效的我发现,改变对不当(局部风险控制指标要求时效= %杂志的我国发现的)(三)两项新建议,关于我的行为的紊乱和混乱的老话题——包括NL和其他精神药物的正确位置(E,S)和新的非药物护理技术(A)——支持减少处方前后的NL暴露。临床影响的衡量是在国家一级通过在三个主要健康保险计划的法国所有MA人口中测量的MA对NL的暴露率来进行的。结果2007年对近40万am的首次全国测量证实,NL暴露量是同龄普通人群(2.9%)的5倍(16.95%)。在启动阿尔茨海默病计划和提高家庭和保健专业人员对非传染性疾病风险的认识一年后,这一比率略有下降(16.1%,相当于避免了3500次接触)。综合方案的所有要素,同时打击iatrogénie NL正在建立的、有成果的传播——尤其是全国预警指标——得到广泛支持的培训活动和公众信息、家庭和保健专业人员进行老年痴呆症,HAS和计划所职业院校。讨论和结论这一综合方案将护理人员、患者、家庭和卫生机构聚集在一起,并受益于一个国家预警指标,该指标可在实地使用,从护理人员到公众的所有人都能理解。一年后的结果令人鼓舞。该计划预计,到2014年,根据精神病的流行程度,MA的适当NL处方将减少约5%。
{"title":"282 Reducing the iatrogenicity of neuroleptics in patients with Alzheimer's disease","authors":"A. Desplanques-Leperre, N. Riolacci-Dhoyen, M. Erbault, L. Banaeï-Bouchareb, C. Chan-Chee, J. Deligne, V. Corre, P. Ricordeau, B. Lavallart","doi":"10.1136/QSHC.2010.041608.21","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041608.21","url":null,"abstract":"Background and Objectives Neuroleptics (NL) are often prescribed to patients with Alzheimer's disease (AD), mainly for behaviour disorders and during episodes of confusion. However, these drugs are known to have frequent and severe iatrogenic effects: treating 1000 patients with behaviour disorders receiving NL for 12 weeks would result in 10 additional deaths, 18 strokes (half of which were severe), additional 58 to 94 cases of gait disorders and only 91 to 200 decrease in behaviour disorders. In fact, all AD patients will present behaviour disorders at some time or other. The French Alzheimer public health plan aims to reduce the avoidable iatrogenic effects of NL. Program The national cooperative group for the optimisation of the prescription of psychotropic drugs in the elderly was established at the initiative of HAS. Its members include nurses, patients, insurers and institutions. A problem-solving approach centred on the patient pathway that included three quality dimensions (Efficacy (E), Safety (S) and Access to best care (A)) was used to develop and implement the tools to achieve an integrated programme going ‘from practice improvement to clinical impact measurement’. The practice improvement part which is aimed at reducing the iatrogenic effects of NL in AD patients includes: (1) identification of AD patients with NL (local warning signal=percentage of AD patients taking NL). This indicator is easy to measure in all care sectors and comes with a good practice indicator ‘absence of daytime sedation’ and monitoring of prescriptions for other psychotropic drugs to prevent drug switching, (2) review of prescriptions for identified AD patients in order to correct inappropriate prescriptions (local indicator for risk containment=percentage of prescriptions reviewed for AD patients), and (3) two new guidelines on behaviour disorders in AD patients and on confusion in the elderly that describe proper use of NL and other psychotropic drugs (E, S) as well as new nondrug techniques of care (A). Reduction of exposure to NL before and after prescription is based on these guidelines. Clinical impact is given by the national rate of exposure of AD patients to NL and is measured in the French AD patient population covered by the three main sickness funds. Results The first national measures in 2007 on 400 000 AD patients showed that exposure to NL in AD patients was five times higher (16.95%) than in the general population of the same age (2.9%). One year after the Alzheimer plan was launched and after raising the awareness of families and health professionals to the risks of NL, exposure had fallen slightly to 16.1% (equivalent to 3500 fewer cases of exposure). The above programme is in the process being implemented. Results for the national warning signal have been widely diffused. The programme is supported by training initiatives and information campaigns aimed at the general public, the families of AD patients, and health professionals. These are","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"26 1","pages":"A22 - A23"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82865853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
291 Improved management of surgical paediatric patients by computerised selection of medical files for analysis in morbidity monitoring staff meetings 291 .通过计算机选择医疗档案以供发病率监测工作人员会议分析,改进了对外科儿科病人的管理
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041624.37
J. Breaud, Griffet Jacques, Julie Manuel, Bensaid Ronny, M. Carine, J. Quaranta
Background and objectives For Morbidity Monitoring Staff (MMS) meetings to be efficient, they need to include all patient files concerned with medical failures or logistics failures. The major difficulty is selecting all relevant files. Our objective was to develop a computer application that would select the files that need to be discussed in order to identify medical failures and logistics failures that need remedying. Programme The computer application for automatic file selection is based on a comparison of the actual length of hospital stay with the predicted length of stay for a given disease and/or surgical procedure. Every 2 months, all selected files are reviewed to determine which files are incomplete, which relate to medical failures, and which to logistics failures. Results During the 30-month period from January 2006 to April 2009, 8540 children underwent surgery in our department. A total of 1364 (16%) medical files were automatically selected for review by MMS. A total of 51 cases (0.6%) of medical failure and 16 cases (0.19%) of logistics failure were identified and analysed. Three improvement actions ensued: (i) the development of a specific multidisciplinary medical file for ASA III patients, (ii) routine bacteriological analysis in cases of appendectomy in order to fight antibiotic-resistant infections better, (iii) changes in the organisation of day-care surgery (phone-call the day before and after surgery, changes in the timetable…) Conclusion The automated procedure for the selection of medical files for review by MMS helped us identify medical failures (0.6% rate) and initiate specific actions in order to improve health care delivery in our department. Our tool may be useful for MMS in all cases of scheduled hospitalisation or elective surgery. Introduction l'amélioration des pratiques professionnelles repose entre autre sur la réalisation au sein des équipes médicales et paramédicales de RMM. Toutefois, la sélection des dossiers à analyser dépend le plus souvent d'une évaluation individuelle de la survenue d'un évènement porteur de risque ou d'une complication et n'est pas toujours exhaustive. Afin de pallier à cette situation, nous avons développé un système automatique de sélection des dossiers à analyser, basé sur la durée du séjour hospitalier et le caractère complet ou nom du dossier (présence de résumé d'activité médicale et de compte rendu opératoire). Ce mode de sélection nous permettant d'extraire les dossiers incomplets et de les finaliser, mais aussi de mettre en exergue les complications médicales et les problèmes organisationnels. Matériel et méthodes Une application informatique développée sur le logiciel ACCESS (microsoft*) permet, pour chaque patient opéré dans le service, de comparer la durée de l'hospitalisation effectuée à la durée prévisible de l'hospitalisation pour la pathologie et le geste chirurgical concerné. Ainsi, tout patient dont la durée dépasse la d
背景和目的发病率监测工作人员(MMS)会议要有效率,他们需要包括所有与医疗失败或后勤失败有关的患者档案。主要的困难是选择所有相关的文件。我们的目标是开发一个计算机应用程序,它可以选择需要讨论的文件,以确定需要补救的医疗故障和后勤故障。程序自动选择文件的计算机应用程序是基于对给定疾病和/或外科手术的实际住院时间与预测住院时间的比较。每2个月审查所有选定的文件,以确定哪些文件不完整,哪些与医疗故障有关,哪些与后勤故障有关。结果2006年1月至2009年4月30个月间,我科共收治患儿8540例。MMS共自动选择1364份(16%)医疗文件进行审查。共发现和分析医疗故障51例(0.6%)和后勤故障16例(0.19%)。随后采取了三项改进措施:(i)为ASA III患者建立特定的多学科医疗档案;(ii)阑尾切除术病例的常规细菌学分析,以便更好地对抗抗生素耐药性感染;(III)改变日间护理手术的组织(术前和术后的一天电话通话);结论MMS自动选择医疗文件进行审查的程序帮助我们识别医疗事故(0.6%),并采取具体措施,以提高我科的医疗服务质量。我们的工具可能是有用的MMS在所有情况下,计划住院或择期手术。引言职业实践的职业生涯和职业生涯的职业生涯和职业生涯的职业生涯和职业生涯的职业生涯和职业生涯。最后,将所有的数据汇总起来,将所有的数据汇总起来,将所有的数据汇总起来,将所有的数据汇总起来,将所有的数据汇总起来,将所有的数据汇总起来。在较不稳定的情况下,目前的情况是,我们的系统自动收集和分析了所有的数据,我们的系统自动收集和分析了所有的数据,我们的系统自动收集和分析了所有的数据,我们的系统自动收集和分析了所有的数据,完成了所有的数据。这些模数都是由不同的模数组成的,它们都是由不同的模数组成的,它们都是由不同的模数组成的。matriel et msamthodes Une application informatique danalys ys (microsoft*) permission (logiciel ACCESS) permission, pour chque patient opsamro . dansle service, de compare la dursamro . de l'hospitalisation效果,la dursamro . pracro . datos病理,以及其他一些外科问题。在印度,病人不要用“a dursame”代替“a dursame”,而是用“a dursame”代替“a dursame”。我将分析多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科、多学科。30 mois(2006年1月至2009年6月)8540个婴儿使用了 ()和 ()服务。在RMM中,有1364个档案(16%)是由 材料和材料组成的,包括 材料和材料组成的。51份档案(0.6%)涉及到 职业健康组织和 职业健康组织和职业健康组织(19%)。为了分析回顾des档案有的生几个次准备倒拉撬en电荷des病人告诉问:la宪法d一个档案病人multidisciplinaire pre等post-operatoire倒les病人ASA三世。laremationationd 'une分析bactsamriologique en cas d' appendicatique afin de faire face, '幻影'幻影de germerisistants aux抗生素通常。病人流动医疗机构的变更(上诉:taccel tsamelsamoniques La veille et le lendemain de l'intervention, horaire d'admission…)。结论:采用“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”、“利用”。让所有人都知道,所有的人都有自己的生活方式,例如,所有的人都有自己的生活方式,所有的人都有自己的生活方式。
{"title":"291 Improved management of surgical paediatric patients by computerised selection of medical files for analysis in morbidity monitoring staff meetings","authors":"J. Breaud, Griffet Jacques, Julie Manuel, Bensaid Ronny, M. Carine, J. Quaranta","doi":"10.1136/QSHC.2010.041624.37","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041624.37","url":null,"abstract":"Background and objectives For Morbidity Monitoring Staff (MMS) meetings to be efficient, they need to include all patient files concerned with medical failures or logistics failures. The major difficulty is selecting all relevant files. Our objective was to develop a computer application that would select the files that need to be discussed in order to identify medical failures and logistics failures that need remedying. Programme The computer application for automatic file selection is based on a comparison of the actual length of hospital stay with the predicted length of stay for a given disease and/or surgical procedure. Every 2 months, all selected files are reviewed to determine which files are incomplete, which relate to medical failures, and which to logistics failures. Results During the 30-month period from January 2006 to April 2009, 8540 children underwent surgery in our department. A total of 1364 (16%) medical files were automatically selected for review by MMS. A total of 51 cases (0.6%) of medical failure and 16 cases (0.19%) of logistics failure were identified and analysed. Three improvement actions ensued: (i) the development of a specific multidisciplinary medical file for ASA III patients, (ii) routine bacteriological analysis in cases of appendectomy in order to fight antibiotic-resistant infections better, (iii) changes in the organisation of day-care surgery (phone-call the day before and after surgery, changes in the timetable…) Conclusion The automated procedure for the selection of medical files for review by MMS helped us identify medical failures (0.6% rate) and initiate specific actions in order to improve health care delivery in our department. Our tool may be useful for MMS in all cases of scheduled hospitalisation or elective surgery. Introduction l'amélioration des pratiques professionnelles repose entre autre sur la réalisation au sein des équipes médicales et paramédicales de RMM. Toutefois, la sélection des dossiers à analyser dépend le plus souvent d'une évaluation individuelle de la survenue d'un évènement porteur de risque ou d'une complication et n'est pas toujours exhaustive. Afin de pallier à cette situation, nous avons développé un système automatique de sélection des dossiers à analyser, basé sur la durée du séjour hospitalier et le caractère complet ou nom du dossier (présence de résumé d'activité médicale et de compte rendu opératoire). Ce mode de sélection nous permettant d'extraire les dossiers incomplets et de les finaliser, mais aussi de mettre en exergue les complications médicales et les problèmes organisationnels. Matériel et méthodes Une application informatique développée sur le logiciel ACCESS (microsoft*) permet, pour chaque patient opéré dans le service, de comparer la durée de l'hospitalisation effectuée à la durée prévisible de l'hospitalisation pour la pathologie et le geste chirurgical concerné. Ainsi, tout patient dont la durée dépasse la d","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"134 7‐8","pages":"A83 - A84"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91418797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
259 Measure of the impact of the implementation of organised stroke care in the region lle-de-France 在le-de- france地区实施有组织的卒中护理的影响测量
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041608.17
F. Woimant, R. Simon-Prel, M. Neveux, M. Degrave
Context and Objectives Numerous studies and metaanalysis showed the efficiency of Stroke Units (SU). Organised care has been proven to decrease morbidity and mortality after stroke. In Ile-de-France, there are 16 SU, and among them 10 were created since 2003. The implementation of the SU and of their networks are regularly evaluated on behalf of the regional hospitalisation agency (ARH-IF), with information feedback to multidisciplinary stroke teams and hospital administrators to optimise the quality of care of stroke patients. Description of the Program Two types of indicators are collected. Epidemiological data such as number of hospital admissions for stroke in the region and by territory and establishment and demographic data of stroke patients are analysed. Since 2000, they are collected from the national hospital discharge database, according to a protocol of extraction defined by the professionals. Other indicators concern the hospital management of stroke patients such as proportion of patients admitted in SU vs other nondedicated units, the type of stroke (transient ischaemic attacks, infarction and haemorrhage), the stroke severity, the treatments (including rehabilitation), the complications, the length of hospital stay and the outcome. Time indicators are important to assess the organisation of the care: delay of hospitalisation, of admission within the SU, of access to the neurological expertise, to the brain imaging, to the physiotherapist and speech therapist evaluation and to the stroke rehabilitation unit. These data are prospectively collected from surveys regularly realised on 30 to 50 consecutive patients admitted in SU and stroke rehabilitation wards. A web-based tool was used to collect data from sites. The analysis is realised by the pole ‘Affaires hospitalières de la CRAMIF’. The results of these evaluations are presented during an ARH-IF plenary session to the neurologists, the rehabilitation physicians and the hospital administrators of the concerned establishments, and then within each establishment with all the medical and non-medical multidisciplinary team and the directors. Results These evaluations permit to estimate, in an iterative way, the professional practices and to suggest actions to improve organisation of stroke care, measured in particular on patients' proportion admitted in SU, on the decrease of pre-and intra-hospital delays allowing more patients to have access to the thrombolytic therapy. Within Ile-de-France”, the number of stroke patients admitted in establishments with SU increased from 22% to 48.5% between 2003 and 2008; the median age of stroke patients did not modify in the region (71 years), but the age of stroke patients admitted in establishments with SU increased from 63 to 67 years. The in-hospital stroke mortality decreased from 15.8% to 10.5% and the SU- mortality from 12.5% to 8.6%. The number of patients evaluated within the first 48 h by a physiotherapist and/or a speech therapist incr
背景和目的大量研究和荟萃分析表明卒中单位(SU)的有效性。有组织的护理已被证明可以降低中风后的发病率和死亡率。法兰西岛共有16所大学,其中10所是2003年以后成立的。代表区域住院机构(ARH-IF)定期评估辅助医疗系统及其网络的实施情况,并将信息反馈给多学科中风小组和医院管理人员,以优化中风患者的护理质量。项目描述收集了两类指标。分析了流行病数据,如该区域和按领土划分的中风住院人数,以及中风患者的机构和人口数据。自2000年以来,根据专业人员定义的提取协议,从国家医院出院数据库中收集这些数据。其他指标涉及脑卒中患者的医院管理,如住院的患者比例与其他非专用单位,中风的类型(短暂性缺血发作,梗死和出血),中风的严重程度,治疗(包括康复),并发症,住院时间和结果。时间指标对于评估护理的组织很重要:延迟住院、在苏内住院、获得神经学专业知识、脑成像、物理治疗师和语言治疗师评估以及中风康复部门。这些数据是通过定期对30 - 50名连续入住SU和中风康复病房的患者进行调查收集的。使用基于网络的工具从网站收集数据。这一分析是通过“医院事务部门”实现的。这些评估的结果在ARH-IF全体会议期间提交给有关机构的神经科医生、康复医生和医院管理人员,然后在每个机构内提交给所有医疗和非医疗多学科小组和主任。结果这些评估允许以迭代的方式估计专业实践,并提出改进卒中护理组织的行动建议,特别是测量患者在SU住院的比例,减少院前和院内延误,使更多患者能够获得溶栓治疗。在法兰西岛,2003年至2008年期间,在suu机构住院的中风患者人数从22%增加到48.5%;卒中患者的中位年龄在该地区没有变化(71岁),但在SU机构住院的卒中患者的年龄从63岁增加到67岁。住院卒中死亡率从15.8%下降到10.5%,SU死亡率从12.5%下降到8.6%。在最初48小时内由物理治疗师和/或语言治疗师评估的患者数量有规律地增加,而并发症发生率下降。结论:对区域卒中护理途径的定期评估可以提供和量化卒中人群中某些过程和护理质量的相关可靠信息。这些客观数据允许专业人员之间交换观点,建议更好的组织,跟踪其实施并衡量改进计划的临床影响。背景和目的:研究和分析<s:1>神经血管系统与<s:1>神经血管系统与<s:1>神经血管系统与<s:1>神经血管系统与<s:1>神经系统与神经系统;在事故发生后,心血管疾病(AVC)与其他疾病(AVC)有很大的关系。在法兰西岛,将有16个联合国志愿人员,2003年将有10个联合国志愿人员代表。在治疗过程中,将患者的身体和神经血管的功能与患者的身体进行比较,将患者的身体功能与患者的身体功能进行比较,将患者的身体功能与患者的身体功能进行比较,将患者的身体功能与患者的身体功能进行比较,将患者的身体功能与患者的身体功能进行比较。参数名称参数含义参数项参数项分为两种类型。在2000年,由PMSI和MCO共同制定的《关于从专业人员中提取与其他职业人员有关的薪金薪金的议定书》:从医疗人员中提取与其他职业人员有关的薪金薪金;从医疗人员中提取与其他职业人员有关的薪金薪金;从医疗人员中提取与其他职业人员有关的薪金薪金;从医疗人员中提取与其他职业人员有关的薪金薪金;从医疗人员中提取与其他职业人员有关的薪金薪金;从患者中提取与其他职业人员有关的薪金薪金。这些指标包括:医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构、医疗机构和医疗机构。治疗条件、治疗对象、病人比例、联合国志愿人员与医院、住院医师、病状性质、治疗过程、治疗(包括治疗过程)、治疗过程、治疗过程、并发症和治疗方式。 评估该部门运作的许多重要时间也被记录下来:住院时间、获得神经学专业知识、成像、进入专门单位、物理治疗和语言评估、获得后续护理和康复服务(SSR)。这些调查的数据直接输入互联网服务器。他们的分析是由CRAMIF的“医院事务”pole进行的。这些评估的结果将在全体会议上提交给arh - if,该会议汇集了有关机构的神经学家、康复医生和主任,然后在每个机构内与医疗和非医疗保健专业人员以及行政人员一起提交。这些评估结果进行评估的方式组织和专业做法考虑迭代改进行动,旨在测量病人的护理质量,特别是对名就诊的病人比例,降低时间前后intra-hospitaliers使超过thrombolyse患者享用。在该地区,2003年至2008年期间,在有UNV设施的中风患者人数从22%上升到48.5%;中风患者的平均年龄并未改变地区(71岁),但中风病人的院校录取,与名增至63至67岁。中风住院死亡率总体下降了15.8%至10.5%,短期逗留,而有一名院校的12.5%至8.6%。在最初的48小时内,由物理治疗师和/或语言治疗师评估的患者数量稳步增加,而住院期间并发症的发生率下降。结论定期评估神经血管通路可以客观量化患者管理的相关参数。这些客观因素,使论证与非医疗,医疗小组讨论、设立各个方向以organsation opitimale照顾中风的量子,提出改进运作、监测其实施临床并衡量其影响。
{"title":"259 Measure of the impact of the implementation of organised stroke care in the region lle-de-France","authors":"F. Woimant, R. Simon-Prel, M. Neveux, M. Degrave","doi":"10.1136/QSHC.2010.041608.17","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041608.17","url":null,"abstract":"Context and Objectives Numerous studies and metaanalysis showed the efficiency of Stroke Units (SU). Organised care has been proven to decrease morbidity and mortality after stroke. In Ile-de-France, there are 16 SU, and among them 10 were created since 2003. The implementation of the SU and of their networks are regularly evaluated on behalf of the regional hospitalisation agency (ARH-IF), with information feedback to multidisciplinary stroke teams and hospital administrators to optimise the quality of care of stroke patients. Description of the Program Two types of indicators are collected. Epidemiological data such as number of hospital admissions for stroke in the region and by territory and establishment and demographic data of stroke patients are analysed. Since 2000, they are collected from the national hospital discharge database, according to a protocol of extraction defined by the professionals. Other indicators concern the hospital management of stroke patients such as proportion of patients admitted in SU vs other nondedicated units, the type of stroke (transient ischaemic attacks, infarction and haemorrhage), the stroke severity, the treatments (including rehabilitation), the complications, the length of hospital stay and the outcome. Time indicators are important to assess the organisation of the care: delay of hospitalisation, of admission within the SU, of access to the neurological expertise, to the brain imaging, to the physiotherapist and speech therapist evaluation and to the stroke rehabilitation unit. These data are prospectively collected from surveys regularly realised on 30 to 50 consecutive patients admitted in SU and stroke rehabilitation wards. A web-based tool was used to collect data from sites. The analysis is realised by the pole ‘Affaires hospitalières de la CRAMIF’. The results of these evaluations are presented during an ARH-IF plenary session to the neurologists, the rehabilitation physicians and the hospital administrators of the concerned establishments, and then within each establishment with all the medical and non-medical multidisciplinary team and the directors. Results These evaluations permit to estimate, in an iterative way, the professional practices and to suggest actions to improve organisation of stroke care, measured in particular on patients' proportion admitted in SU, on the decrease of pre-and intra-hospital delays allowing more patients to have access to the thrombolytic therapy. Within Ile-de-France”, the number of stroke patients admitted in establishments with SU increased from 22% to 48.5% between 2003 and 2008; the median age of stroke patients did not modify in the region (71 years), but the age of stroke patients admitted in establishments with SU increased from 63 to 67 years. The in-hospital stroke mortality decreased from 15.8% to 10.5% and the SU- mortality from 12.5% to 8.6%. The number of patients evaluated within the first 48 h by a physiotherapist and/or a speech therapist incr","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"11 1","pages":"A18 - A19"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83583950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
133 Clinical pathways in post-anaesthesia care unit to reduce length of stay, mortality and unplanned intensive care unit admission 133麻醉后护理病房的临床途径,以减少住院时间、死亡率和计划外的重症监护病房入住
Pub Date : 2010-04-01 DOI: 10.1136/QSHC.2010.041624.31
A. Eichenberger, G. Haller, B. Walder
Introduction The aim of the study was to assess the impact of a clinical pathway implemented in a post-anaesthesia care unit (PACU) on postoperative outcomes. Methods A patient clinical pathway which includes a nurse-driven fast track program (FTP) for uncomplicated patients and minor interventions and a medical-driven slow track program (STP) for complicated patients were implemented over a period of 2 months. A retrospective cohort study based on electronic patient records was performed to assess the effectiveness of this program on PACU and hospital length of stay (LOS) and in-hospital mortality and unplanned admission to the intensive care unit (ICU). We compared the period before and after implementation of the program. Statistical analysis was performed using the Student t test, χ2, Wilcoxon-rank test. Multivariate analysis using linear and logistic regression was performed to adjust for differences in patient demographic characteristics, co-morbidities, type of surgery and anaesthesia and emergency status between the two periods. A p≤0.05 was considered significant. Results Patients characteristics, ASA scores, type of anaesthesia and surgery were similar before and after implementation of the clinical pathways. We observed a decrease in PACU median length of stay for all patients from 163 min (IQR, 103–291) to 148 min (IQR, 96–270 min) (p<0.001). In ASA 1-2 patients median LOS in PACU decreased from 152 min (IQR, 102–249 min) to 135 min (IQR 91–227 min) in ASA 1-2 patients (p<0.001). Hospital LOS however remained unchanged. Overall in-hospital mortality after pathway implementation decreased for all patients from 1.7 to 0.9% (adjusted OR 0.36 (95%CI 0.22 to 0.59), p value<0.01). The number of unplanned admissions to ICU decreased also from 113 (2.8%) to 91 (2.1%) (adjusted OR 0.73 (95%CI 0.53 to 0.99); p value 0.04). Conclusion A significant reduction of LOS in PACU, in-hospital mortality and unplanned admission to ICU was observed after implementation of a clinical pathway in the PACU. Introduction La phase postopératoire est une phase risquée pour le patient en terme de complications. La mortalité postopératoire actuelle, tous actes chirurgicaux confondus, se situe entre 1.2 et 2.6%, alors que la morbidité est supérieure à 11%. Dans notre salle de surveillance post-interventionnel (SSPI), nous avons un flux important de patients en bonne santé habituelle ayant bénéficié d'un acte chirurgical mineur et des patients polymorbides ayant bénéficié d'une chirurgie majeure. Nous avons mis en application un programme de prise en charge des patients permettant de libérer rapidement ceux en bonne santé habituelle sur la base de critères cliniques standardisés de manière à libérer les ressources de soins nécessaires pour la prise en charge des patients à haut risque de complications. But de l’étude Le but de cette étude était d’évaluer les bénéfices d'un programme de qualité incluant deux itinéraires cliniques distin
本研究的目的是评估在麻醉后护理单位(PACU)实施的临床路径对术后结果的影响。方法采用为期2个月的患者临床路径,对病情简单的患者实施护士驱动的快速通道方案(FTP)和轻微干预措施,对病情复杂的患者实施医疗驱动的慢通道方案(STP)。一项基于电子病历的回顾性队列研究评估了该方案对PACU、住院时间(LOS)、住院死亡率和非计划入住重症监护病房(ICU)的有效性。我们比较了项目实施前后的情况。统计学分析采用Student t检验、χ2、wilcox -rank检验。使用线性和逻辑回归进行多变量分析,以调整患者人口统计学特征、合并症、手术类型和麻醉以及两个时期的急诊状态的差异。A p≤0.05被认为是显著的。结果实施临床路径前后患者特征、ASA评分、麻醉方式及手术方式相似。我们观察到所有患者PACU的中位住院时间从163分钟(IQR, 103-291)减少到148分钟(IQR, 96-270分钟)(p<0.001)。ASA 1-2患者PACU的中位LOS从152 min (IQR, 102-249 min)降至135 min (IQR, 91-227 min) (p<0.001)。然而,医院LOS保持不变。实施路径后,所有患者的住院总死亡率从1.7%降至0.9%(校正OR 0.36 (95%CI 0.22 ~ 0.59), p值<0.01)。非计划入住ICU的人数也从113例(2.8%)下降到91例(2.1%)(调整OR 0.73 (95%CI 0.53 ~ 0.99);P值0.04)。结论在PACU实施临床路径后,可显著降低PACU的LOS、住院死亡率和非计划入院率。一期手术后的患者和一期手术后的患者均出现并发症。死亡统计数据(死亡统计数据)、疾病统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)、死亡统计数据(死亡统计数据)等。在介入后监测中(SSPI),我们注意到一些重要的因素,如患者在手术过程中是否存在不可抗力,如习惯性的不可抗力,或是否存在不可抗力,或是否存在多病性的不可抗力。目前的情况是,在应用程序中,对病人进行收费,对病人进行渗透,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对并发症,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费,对病人的收费。但是,在所有的电子表格中,所有的电子表格和电子表格都包含了电子表格和电子表格,包括电子表格和电子表格,电子表格和电子表格,电子表格和电子表格,电子表格和电子表格,电子表格和电子表格,电子表格和电子表格,电子表格和电子表格,电子表格和电子表格。描述方案和m - ims - ms - ims - ms - ms - ms - ms - ms - ms - ms - ms - ms - ms - ms第一阶段的<s:1>医疗器械和医疗器械的<s:1>医疗器械和医疗器械的<s:1>医疗器械和医疗器械的医疗器械(FTP:快速通道);在第二阶段,如“多病合并”、“不可抗力合并”、“不可抗力合并”、“不可抗力合并”、“不可抗力合并”。目前的研究对象包括:成年(≥18岁)患者和成年(≥18岁)患者,均采用SSPI治疗,但不能采用单纯的手术治疗,也不能采用单纯的手术治疗,也不能采用单纯的麻醉治疗。《关于薪金和其他方面的信息原则》是关于薪金和其他方面的资料,关于薪金和其他方面的资料是关于薪金和其他方面的。Les p10.1.2007和2008年1月1日分别于2007年1月1日和2007年7月31日(avant l' implicationdu programme)和2008年1月1日和2008年7月31日(apr<s:1> l' implicationdu programme)。在收集申诉者、管理和利用申诉者的基础上(DPI)和利用和利用申诉者的基础上(DPI),关于申诉和利用申诉者的注意事项的说明,说明了申诉和利用申诉者的情况。不能用其他的形式来代替其他的形式。将有身份的和有身份的、有身份的、有身份的和有身份的。<s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> <s:1> - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -在2007年10月1日(148分钟),在2008年(96分钟),在2008年4月1日(148分钟),在2008年1月1日(148分钟),在2007年1月1日(148分钟),在2008年1月1日(148分钟),在2008年1月1日(p<0。
{"title":"133 Clinical pathways in post-anaesthesia care unit to reduce length of stay, mortality and unplanned intensive care unit admission","authors":"A. Eichenberger, G. Haller, B. Walder","doi":"10.1136/QSHC.2010.041624.31","DOIUrl":"https://doi.org/10.1136/QSHC.2010.041624.31","url":null,"abstract":"Introduction The aim of the study was to assess the impact of a clinical pathway implemented in a post-anaesthesia care unit (PACU) on postoperative outcomes. Methods A patient clinical pathway which includes a nurse-driven fast track program (FTP) for uncomplicated patients and minor interventions and a medical-driven slow track program (STP) for complicated patients were implemented over a period of 2 months. A retrospective cohort study based on electronic patient records was performed to assess the effectiveness of this program on PACU and hospital length of stay (LOS) and in-hospital mortality and unplanned admission to the intensive care unit (ICU). We compared the period before and after implementation of the program. Statistical analysis was performed using the Student t test, χ2, Wilcoxon-rank test. Multivariate analysis using linear and logistic regression was performed to adjust for differences in patient demographic characteristics, co-morbidities, type of surgery and anaesthesia and emergency status between the two periods. A p≤0.05 was considered significant. Results Patients characteristics, ASA scores, type of anaesthesia and surgery were similar before and after implementation of the clinical pathways. We observed a decrease in PACU median length of stay for all patients from 163 min (IQR, 103–291) to 148 min (IQR, 96–270 min) (p<0.001). In ASA 1-2 patients median LOS in PACU decreased from 152 min (IQR, 102–249 min) to 135 min (IQR 91–227 min) in ASA 1-2 patients (p<0.001). Hospital LOS however remained unchanged. Overall in-hospital mortality after pathway implementation decreased for all patients from 1.7 to 0.9% (adjusted OR 0.36 (95%CI 0.22 to 0.59), p value<0.01). The number of unplanned admissions to ICU decreased also from 113 (2.8%) to 91 (2.1%) (adjusted OR 0.73 (95%CI 0.53 to 0.99); p value 0.04). Conclusion A significant reduction of LOS in PACU, in-hospital mortality and unplanned admission to ICU was observed after implementation of a clinical pathway in the PACU. Introduction La phase postopératoire est une phase risquée pour le patient en terme de complications. La mortalité postopératoire actuelle, tous actes chirurgicaux confondus, se situe entre 1.2 et 2.6%, alors que la morbidité est supérieure à 11%. Dans notre salle de surveillance post-interventionnel (SSPI), nous avons un flux important de patients en bonne santé habituelle ayant bénéficié d'un acte chirurgical mineur et des patients polymorbides ayant bénéficié d'une chirurgie majeure. Nous avons mis en application un programme de prise en charge des patients permettant de libérer rapidement ceux en bonne santé habituelle sur la base de critères cliniques standardisés de manière à libérer les ressources de soins nécessaires pour la prise en charge des patients à haut risque de complications. But de l’étude Le but de cette étude était d’évaluer les bénéfices d'un programme de qualité incluant deux itinéraires cliniques distin","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"13 1","pages":"A78 - A78"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85897084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
148 Patient information: definition of indicators on the quality of disclosures to patients 148患者信息:对患者信息披露质量指标的定义
Pub Date : 2010-04-01 DOI: 10.1136/qshc.2010.041632.26
A. Vitoux, F. Farsi, C. Grenier
Context and Objectives The disclosure protocol, defined in the first French cancer plan, is intended to benefit patients, giving them better conditions for disclosing their illness and the treatment plan proposed, and this throughout its management. This protocol relies on a multidisciplinary management involving primarily physicians (medical time) and paramedics (accompanying time) and aims to inform and accompany the patients and their family. The quality of patient information is considered as a crucial point for quality of care. Our program has been set up to improve its modalities. The objectives of this program are the following: Description of the current situation, Feedback on experiences Implementation of improvement projects Demonstration of the progress made Programme Six Comprehensive Cancer Centers (CCCs) were involved in a voluntary program. First, the most important aspects of the disclosure protocol were identified. Six valid, reproductible and discriminative quality indicators (QIs) were developed. Each of these QIs includes several items. The relative weight of each item was defined from the quotation of items by participants and experts in terms of relative importance. Each QI was quoted on a scale from 0 to 1. In the CCCs involved in the program, an audit (September 2008) was performed using medical records of 60 new patients who were under treatment (surgery, chemotherapy and/or radiotherapy) for a new cancer. This retrospective audit was used to establish the state of practices. Professional practices were benchmarked between the different CCCs and weaknesses were identified. Improvement actions to be implemented have been discussed and a specific quality plan has been set up in each CCC. Results The assessed QIs were respectively: the disclosure process: mean score=0.63, range: 0.53–0.76 continuity of care: mean score=0.61, range: 0.00–0.75 consideration of patient needs: mean score=0.46, range: 0.26–0.68, information delivered to the patient: mean score=0.28, range 0.25–0.30, patient feelings: mean score=0.27, range 0.09–0.37 needs of relatives for support: mean score=0.26, range 0.02–0.44 Even if the lack of traceability may explain a large part of measured quality defaults, professionals also identified the need to precise the good practices, to disseminate them and to structure the modalities of the disclosure process for each patient. This process has been standardised in each center. A systematic production of a personalised care program for each patient is still ongoing. Some skills have already been developed by professionals (e.g. information delivered to the patient, information process, adaptation to patient singular choices, information check list) and shared between CCCs. Conclusion The second audit will be conducted in February 2010 and the comparison of results for each hospital may demonstrate the progress made. Thus, consistency of such programs can be discussed in April 2010. Such an approach is required i
每个中心接受治疗(手术、放疗和/或化疗)的癌症病理(不包括复发)。专业人员对结果进行分析,从而确定弱点和改进的空间。已确定改善措施,并于2009年实施。6项指标的结果(结果一个指标就可以进入一个从0到1),以“组织”宣布,比分是2008年的0.63、0.53 - 0.76[]为“2008”保健的连续性,比分是0.61,0.75[0.00%]为“主流”需求,比分是2008年的0.46]、[0.26至0.68对于病人的“新闻”,比分是2008年的0.28,0.25至0.30[]为“回归患者的理解和反应的病人()”,2008年的得分为0.27,[0.09 - 0.37]对于“支持环境”,2008年的得分为0.26,[0.02 - 0.44]除了可追溯性规则的提醒,改进行动涉及到公告咨询的结构和/或计算机化。还讨论了PPS的系统化。在此过程中创建的文件或程序(标准化PPS、建立最低限度内容、可追溯性检查表等)旨在在参与该过程的机构之间共享。这些行动的影响将在2010年2月通过第二项措施客观化,并可能在2010年4月提出。指标的迭代测量也使质量改进过程能够持续下去。最后,此举d’EPP亦可认证范围内动员V2010授权书中,为了符合质量标准的癌症治疗和预测癌症计划2、19、强化措施实现赔付(认捐机制的质量和PPS)。
{"title":"148 Patient information: definition of indicators on the quality of disclosures to patients","authors":"A. Vitoux, F. Farsi, C. Grenier","doi":"10.1136/qshc.2010.041632.26","DOIUrl":"https://doi.org/10.1136/qshc.2010.041632.26","url":null,"abstract":"Context and Objectives The disclosure protocol, defined in the first French cancer plan, is intended to benefit patients, giving them better conditions for disclosing their illness and the treatment plan proposed, and this throughout its management. This protocol relies on a multidisciplinary management involving primarily physicians (medical time) and paramedics (accompanying time) and aims to inform and accompany the patients and their family. The quality of patient information is considered as a crucial point for quality of care. Our program has been set up to improve its modalities. The objectives of this program are the following: Description of the current situation, Feedback on experiences Implementation of improvement projects Demonstration of the progress made Programme Six Comprehensive Cancer Centers (CCCs) were involved in a voluntary program. First, the most important aspects of the disclosure protocol were identified. Six valid, reproductible and discriminative quality indicators (QIs) were developed. Each of these QIs includes several items. The relative weight of each item was defined from the quotation of items by participants and experts in terms of relative importance. Each QI was quoted on a scale from 0 to 1. In the CCCs involved in the program, an audit (September 2008) was performed using medical records of 60 new patients who were under treatment (surgery, chemotherapy and/or radiotherapy) for a new cancer. This retrospective audit was used to establish the state of practices. Professional practices were benchmarked between the different CCCs and weaknesses were identified. Improvement actions to be implemented have been discussed and a specific quality plan has been set up in each CCC. Results The assessed QIs were respectively: the disclosure process: mean score=0.63, range: 0.53–0.76 continuity of care: mean score=0.61, range: 0.00–0.75 consideration of patient needs: mean score=0.46, range: 0.26–0.68, information delivered to the patient: mean score=0.28, range 0.25–0.30, patient feelings: mean score=0.27, range 0.09–0.37 needs of relatives for support: mean score=0.26, range 0.02–0.44 Even if the lack of traceability may explain a large part of measured quality defaults, professionals also identified the need to precise the good practices, to disseminate them and to structure the modalities of the disclosure process for each patient. This process has been standardised in each center. A systematic production of a personalised care program for each patient is still ongoing. Some skills have already been developed by professionals (e.g. information delivered to the patient, information process, adaptation to patient singular choices, information check list) and shared between CCCs. Conclusion The second audit will be conducted in February 2010 and the comparison of results for each hospital may demonstrate the progress made. Thus, consistency of such programs can be discussed in April 2010. Such an approach is required i","PeriodicalId":20849,"journal":{"name":"Quality and Safety in Health Care","volume":"24 1","pages":"A171 - A172"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90803090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Quality and Safety in Health Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1